Drug comparisons
Erenumab vs Diflunisal
Erenumab (Aimovig) prevents migraines as a CGRP blocker; Diflunisal (Dolobid) is an NSAID for arthritis pain with black-box risks. Compare uses and safety.
No comparison dimensions are available for this page.
Clinical context
Patients researching migraine prophylaxis versus NSAID options for chronic pain or arthritis often trigger this comparison.
Bottom line
Erenumab and Diflunisal address different pain mechanisms and neither is universally better.
All medication comparisons